
BOL Pharma delivers cannabinoid related products and APIs to the pharmaceutical industry worldwide based on extensive know-how and experience in crop production and research.
BOL Pharma has been pioneering the creation of the medical cannabis industry in israel since 2007. The company sources 99% pure pharma grade CBD, THC, and other active ingredients from its own organic GAP certified growing facilities and cGMP certified production plant. Collaborating with the Israeli Ministry of Health and under governmental license, BOL serves thousands of patients, Physicians , HMOs, and Medical centers providing cannabis based medical products and cannabinoid active pharmaceutical ingredients (APIs). As a full service contract manufacturer, BOL produces formulations for clinical research and white label services for the pharmaceuticals, food, supplements, and cosmetics industries.
BOL Pharma has been pioneering the creation of the medical cannabis industry in israel since 2007. The company sources 99% pure pharma grade CBD, THC, and other active ingredients from its own organic GAP certified growing facilities and cGMP certified production plant. Collaborating with the Israeli Ministry of Health and under governmental license, BOL serves thousands of patients, Physicians , HMOs, and Medical centers providing cannabis based medical products and cannabinoid active pharmaceutical ingredients (APIs). As a full service contract manufacturer, BOL produces formulations for clinical research and white label services for the pharmaceuticals, food, supplements, and cosmetics industries.
Location: Israel, South District, Revadim
Employees: 51-200
Founded date: 2007
Investors 1
Date | Name | Website |
- | Gandyr Inv... | gandyr.com |
Mentions in press and media 3
Date | Title | Description |
13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but listing offerings from companies around the world, OurCrowd has seen approximately $1.4 billion in committed funding since inception. Of the... |
29.04.2019 | BOL Pharma Grows In A Favorable Climate That Made Israel Leader Of $100B Medical Cannabis Market | BOL Pharma cannabis cultivation facility, Israel BOL Pharma |
20.01.2016 | Israel’s Cannabis Industry Blazes Ahead | Dennis Mitzner Contributor Dennis Mitzner is a journalist and writer with a focus on tech, culture and politics. You can find his commentary here. He also writes about e-commerce and retail for Forbes. More posts by this contributor Magic L... |